Fermenta Biotech promoter Preeti Thakkar sold 11,65,938 equity shares, representing 3.96% of the company's share capital, in the open market on September 28, 2026.

The transaction was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Following the sale, her total holding in the company has decreased from 7.61% to 3.65%.

Shareholding details

The disclosure form indicates that the sale was executed entirely through the open market mechanism. There were no encumbrances, warrants, or convertible securities involved in the transaction prior to or after the sale. The total diluted share capital of the company remained unchanged at ₹14,71,54,935, divided into 2,94,30,987 equity shares of ₹5 each.

Regulatory compliance

The intimation was filed with the BSE and National Stock Exchange on September 29, 2026. The company secretary and head of legal, Varadvinayak Khambete, signed off on the disclosure to the exchanges. The promoter confirmed the trade details in a separate letter to the company's compliance officer, citing the same date and volume for the open market sale.

Fermenta Biotech Limited will host a physical one-to-one investor meeting in Mumbai on September 22, 2026. The company confirmed the schedule through a regulatory filing on September 17, 2026.

The interaction is part of the company's ongoing engagement with stakeholders. Officials from Fermenta Biotech will participate in the session to address queries and discuss operational updates.

Meeting Details

The meeting will be conducted in person, allowing for direct dialogue between company representatives and investors. The location has been fixed at Mumbai, with no virtual component mentioned for this specific interaction.

Regulatory Compliance

The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely and fair disclosure of price-sensitive information to stock exchanges.

Fermenta Biotech stated that no unpublished price-sensitive information (UPSI) is intended to be discussed during the interaction. All relevant press releases and investor presentations available for discussion are already hosted on the company's website and the respective stock exchange portals.

Varadvinayak Khambete, Company Secretary and Head – Legal, signed the intimation letter. He noted that changes to the schedule may occur due to exigencies on the part of the company or investors.